Delhi Cabinet approves emergency procurement of anti-rabies vaccine for govt hospitals

Image
Press Trust of India New Delhi
Last Updated : Oct 16 2019 | 6:40 PM IST

In view of "acute shortage" of anti-rabies vaccine in government hospitals here, the Delhi Cabinet on Wednesday cleared a proposal of the health department for its emergency procurement.

According to a statement, the Cabinet, in its meeting chaired by Chief Minister Arvind Kejriwal, also granted its ex-post facto approval for the already procured 40,000 vials.

"The Cabinet approved the procurement of 80,000 vials of anti-rabies vaccine on a single bid basis and granted its ex-post facto approval for the already procured 40,000 vials," the statement stated.

Anti-rabies vaccine is an essential life saving vaccination administered to dog bite cases to prevent the deadly rabies infection, it said.

"Currently, there is an acute shortage of this vaccine in Delhi hospitals since the Central Procurement Agency (CPA) could not procure due to several reasons -- withdrawal of rate contract by the bidder, poor availability of ARV in the open market and single bid participation in the CPA open tender," the statement stated.

The government said that to tackle the situation a meeting under the chairmanship of Director General of Health Services in the central government was held in Nirman Bhawan.

In the meeting, various decisions were taken to tackle the situation. It was decided all organisations will make all the possible efforts to overcome the shortage and if required, this vaccine may be procured from the public sector undertaking and other state medical service corporations.

Meanwhile, considering the "grim situation", the finance department also accorded approval to purchase 30,000 vials from a particular single source since the availability of this vaccine in the local market is also "very scarce", it said.

During the current financial year 2019-20, there is a budget provision of Rs 297.80 crore under CPA for purchase of medicines, the statement added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 16 2019 | 6:40 PM IST

Next Story